Past Clinical Trials Webinar
SCINAI: 2023 In Review and 2024 Plans
Healthcare > Clinical Trials1/9/2024 3:00 PM
Join Scinai Immunotherapeutics' webinar to learn about 2023 achievements and future plans for innovative treatments. Learn more on WebinarCafe.
Clinical Trials Webinar Benefits
CEO Amir Reichman will review Scinai’s 2023 accomplishments and discuss 2024 plans, including bringing Scinai’s anti-IL-17 VHH antibody (‘NanoAb’) innovative psoriasis treatment into clinical trials by the end of 2024.
Comments
Rate This Webinar
Publisher
Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.